Investor Type

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
Institutional Investor Advisor Individual Investor


International Growth Strategy

Fourth Quarter 2019

Key Takeaways
  • A scaling back of economic and geopolitical uncertainty combined with easing global monetary policy sparked an international equity rally to close the year.
  • The portfolio delivered strong relative and absolute performance for the quarter and the year, supported by contributions from a diversified group of growth companies.
  • Attractive valuations as well as positive technical and currency trends should enable the long-running bull market for non-U.S. growth stocks to continue.
Market Overview

The mood turned positive in international markets in the fourth quarter as several actions removed a measure of uncertainty that plagued investor sentiment for most of 2019. Non-U.S. equities delivered strong results, with the benchmark MSCI ACWI Ex U.S. Index delivering a gain of 8.92%, the MSCI ACWI Ex U.S. Small Cap Index advancing 11.07% and the MSCI Emerging Market Index rising 11.84%. International growth stocks maintained an advantage over their value counterparts with the MSCI ACWI Ex-U.S. Growth Index up 9.58% for the quarter compared to a gain of 8.21% for the ACWI Ex-U.S. Value Index (Exhibit 1).

The fourth-quarter rally was driven by the beneficial impact of rate cuts by the U.S. Federal Reserve, optimism on a conclusion to phase one of a U.S.-China trade deal, signs of global growth stabilization and an apparent resolution in the United Kingdom as the Conservative Party won a majority in the latest election, marking the beginning of the end of Brexit uncertainty.


Exhibit 1: MSCI Growth vs Value Performance

Data as of Dec. 31, 2019. Source: MSCI.


On a regional basis, emerging markets (+12.0%) delivered the best returns followed by the UK (+11.0%). Europe Ex-UK (+8.2%), Japan (+7.6%) and Asia Ex Japan (+6.2%) lagged.

On a sector basis, information technology (IT, +15.5%), consumer discretionary (+11.4%) and materials (+10.8%) outperformed, reflecting a bid to cyclical stocks from a better global economic outlook as well as a preference for companies with the most visible growth prospects. Health care (+12.5%) also outperformed for the second straight quarter as abating headwinds related to an overhaul of the U.S. health care system supported better overall sentiment for the sector. Yield-oriented consumer staples as well as energy and communication services lagged in a strong up market.

Amidst this backdrop, the Strategy outperformed the benchmark for the fourth quarter, completing a strong year of absolute and relative performance (Exhibit 2). Our valuation approach to growth applied across a broad spectrum of growth companies with strict attention to risk management enabled us to weather general market weakness in the third quarter and still participate in more momentum-oriented periods, including the fourth quarter.


Exhibit 2: Recent Performance vs. Benchmark

Data as of Dec. 31, 2019. Source: FactSet.


Chinese e-commerce and payments conglomerate Alibaba rallied late in the year with the apparent thawing of trade tensions between the U.S. and China. Alibaba is a direct play on the Chinese consumer, which is where we see the best near- to medium-term growth trends in the world’s second-largest economy. Alibaba falls in our emerging growth bucket of companies with disruptive business models and above-average growth profiles that can also carry a higher degree of risk. DIY e-commerce tools provider Shopify was also a leading contributor among our emerging growth holdings. We took advantage of post-IPO pricing pressure to add to our emerging bucket with Teamviewer, a German developer of cloud software that allows connectivity solutions for remote access, monitoring and control as well as sharing/communication and collaboration. The company has been aggressively de-leveraging since its third-quarter IPO and is early in the penetration of new clients globally.

Secular growth companies make up the bulk of the portfolio. These are long-term compounders with established business models, leading market positions and strong balance sheets to weather difficult conditions. The portfolio’s semiconductor holdings - Taiwan Semiconductor, ASML and Samsung - performed strongly, driven by improving trade sentiment and what that might mean for future activity in China and other Asian markets. We indirectly added to our semi exposure with the fourth-quarter purchase of Hoya Corp., a Japanese maker of glasses and optical technologies that is seeing a ramp up in its business producing photomasks for chip manufacturing. German enterprise software developer SAP and French luxury goods maker LVMH also drove performance in the secular bucket.

For portfolio balance and to ensure we are not overlooking non-traditional growth opportunities, we also target stocks that we consider structural growth stories. These are companies that are either in a cyclical industry that is coming out of a trough period or are involved in a restructuring or similar change that should lead to a step change in earnings. Here we are seeing good results out of Swiss pharmaceutical makers Roche and Novartis as the drug development thesis begins to play out.

Portfolio Positioning

We added to our bank exposure in the fourth quarter with the purchase of French financial services firm Credit Agricole. France has among the best loan growth in Europe and Credit Agricole is a good self-help story in this market. It has been divesting non-core divisions to reinvest in its higher-yielding existing core businesses. The company is seeing improvement in its investment bank and holds a stake in the solidly growing asset manager Amundi.

To make room in the portfolio for companies with better top-line growth stories, we sold out of seven positions during the quarter. We exited Anheuser-Busch InBev due to disappointing recent results. We had held the stock based on the view debt paydown would accelerate following the IPO of Budweiser Asia Pacific, growth rates would pick up in Asian markets and the company had a low bar to top expectations in its larger markets in the U.S. and Latin America. But weak results in Asia and other key markets exposed increased competitive intensity in the global beer industry and called into question our growth forecasts.


"A valuation approach to growth enabled us to weather market weakness and participate in more momentum-oriented periods."


We also closed out of Canadian oil sands producer Suncor Energy, increasing the portfolio’s energy underweight. We are negative on the relative long-term growth prospects of the fossil fuel energy industry due to abundant supply as well as a weak global demand growth outlook. Supply is addressed by new discoveries while demand is under pressure from regulation and new, more renewable technologies. On a positive note, we sold our stake in Dutch data center operator Interxion ahead of its acquisition by a competitor.


We see reasons for optimism in 2020 that are underpinned by policy moves. The European Central Bank has resumed a measured program of quantitative easing and the U.S. Federal Reserve has lowered interest rates. China and Japan continue to stand ready to provide liquidity to their economies should there be signs of economic weakness. In past cycles, increasing money supply has supported stock values after a several month lag, with the manufacturing sector picking up soon after. International manufacturing PMIs seem to have stabilized with China’s PMI showing improvement. Given the likelihood of a short-term truce in the U.S.-China trade war, which would be supportive for international developed and emerging markets, we are setting the stage for a broad-based recovery by the second half of 2020.

International equity valuations remain attractive, particularly in the United Kingdom and Europe compared with U.S. equities. European stocks are at 50-year lows versus the U.S., which has represented a good entry point the last two times performance dispersions became this extreme. Near-term risks in Italy are contained for now with a new moderate government in place. Fiscal stimulus is being discussed within the EU, which would be a clear positive, while the Brexit saga appears near an end.

Investors remain underinvested in the international equity asset class. While cash allocations have come down from the third quarter, they remain high with plenty of dry powder to put to work. Low expectations and a slow churn higher in the market have left investors on the sidelines. In addition, currency could finally be a tailwind for international returns as yield differentials narrow and the U.S. twin deficits climb (Exhibit 3).

Exhibit 3: Currency Headwinds Could Dissipate

Data as of Sept. 30, 2019, most recent available as of Dec. 31, 2019. Source: BEA, Federal Reserve, FactSet.

We are aware that the bull market is in late stages, but with central bank stimulus and very low interest rates, the markets can continue to perform. Often the last one-to-two years before a recession are strong performance periods. The risks for 2020 are more geopolitical or tied to the potential for central bank policy errors. The latest Middle East developments involving the U.S. and Iran will likely have no major impact in the short term, but could create trouble for the world economy if oil prices spike and sustain levels which impede global growth. In this ever-changing environment, international growth stocks have held up well and our team remains focused on our valuation approach to growth. With this market backdrop, we believe that growth as a category continues to outperform other areas as investors seek growth that is not predominantly economically driven.

Portfolio Highlights

The ClearBridge International Growth Strategy outperformed the benchmark MSCI ACWI ex U.S. Index for the fourth quarter. The Strategy delivered gains across eight of the nine sectors in which it was invested (out of 11 total), with the primary contributors coming from the IT, consumer discretionary and financials sectors.

On a relative basis, overall sector allocation contributed to performance but was partially offset by stock selection effects. In particular, an overweight to IT as well as stock selection in the financials sector drove relative results. Conversely, stock selection in the consumer staples, health care and communication services sectors detracted from relative performance.

On a regional basis, stock selection in Europe Ex UK had a positive impact. Japan, a market that had been very strong through the first nine months of the year, weakened during the fourth quarter, underperforming the market overall. In areas such as industrials and consumer staples some of our Japanese stocks lagged.

Our emerging markets exposure allows us to find strong growth opportunities that provide higher and more sustainable growth ideas than ones we can find in developed markets, particularly Japan. Our positions here are largely oriented to growth in Asia and China, two areas which performed strongly for the quarter.

On an individual stock basis, the largest contributors to absolute returns in the quarter included Alibaba Group, Taiwan Semiconductor, ASML Holdings, Samsung Electronics and Roche. The greatest detractors from absolute returns included positions in Shiseido, Anheuser-Busch InBev, Hansa Biopharma, Arco Platform and Temenos.

In addition to the transactions mentioned above, we initiated positions in Kao in the consumer staples sector, Adyen and Hexagon in the IT sector, Spotify in the communication services sector and XP in the financials sector. We also closed positions in Elixinol Global in consumer staples, Keywords Studios and Amdocs in the IT sector as well as Asos in the consumer discretionary sector.

Elisa Mazen

Head of Global Growth, Portfolio Manager
35 Years experience
12 Years at ClearBridge

Thor Olsson

Portfolio Manager
23 Years experience
20 Years at ClearBridge

Michael Testorf, CFA

Portfolio Manager
33 Years experience
5 Years at ClearBridge

Pawel Wroblewski, CFA

Portfolio Manager
24 Years experience
12 Years at ClearBridge

Related Perspectives

Related News

  • Past performance is no guarantee of future results.

  • All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information. 

  • Performance source: Internal. Benchmark source: Morgan Stanley Capital International. Neither ClearBridge Investments, LLC nor its information providers are responsible for any damages or losses arising from any use of this information. Performance is preliminary and subject to change.

    Neither MSCI nor any other party involved in or related to compiling, computing or creating the MSCI data makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in or related to compiling, computing or creating the data have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. No further distribution or dissemination of the MSCI data is permitted without MSCI’s express written consent. Further distribution is prohibited.